Marketing-authorisation holder · United States
Dr Reddys
32 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
32 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 32
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| APREMILAST10mg | 20mg | 30mg · Tablet | Apremilast | United States | Marketed | 2021 |
| BENDAMUSTINE HYDROCHLORIDE100mg/vial | 25mg/vial · Powder | Bendamustine | United States | Marketed | 2022 |
| BORTEZOMIB3.5mg/vial · Powder | Bortezomib | United States | Not marketed | 2017 |
| CLOPIDOGREL BISULFATE300mg base | 75mg base · Tablet | Clopidogrel | United States | Marketed | 2008 |
| DEFEROXAMINE MESYLATE2gm/vial | 500mg/vial · Injectable | Deferoxamine | United States | Marketed | 2004 |
| DICYCLOMINE HYDROCHLORIDE10mg/ml · Injectable | Dicycloverine | United States | Marketed | 1986 |
| DOCOSANOL10% · Cream | Docosanol | United States | Marketed | 2018 |
| EDARAVONE30mg/100ml (0.3mg/ml) | 60mg/100ml (0.6mg/ml) · Solution | Edaravone | United States | Marketed | 2024 |
| ENALAPRILAT1.25mg/ml · Injectable | Enalapril | United States | Marketed | 2000 |
| ESOMEPRAZOLE MAGNESIUM20mg base · Capsule, delayed release | Esomeprazole | United States | Marketed | 2017 |
| ESTRONE2mg/ml | 5mg/ml · Injectable | Estrone | United States | Not marketed | 1979 |
| FEBUXOSTAT40mg | 80mg · Tablet | Febuxostat | United States | Marketed | 2018 |
| FENTANYL CITRATE PRESERVATIVE FREE0.05mg base/ml · Injectable | Fentanyl | United States | Marketed | 1991 |
| FINGOLIMOD HYDROCHLORIDE0.25mg base | 0.5mg base · Capsule | Fingolimod | United States | Marketed | 2019 |
| GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE1mg base/ml (eq 1mg base/ml) · Injectable | Granisetron | United States | Marketed | 2007 |
| GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE30mg; 600mg | 60mg; 1.2gm · Tablet, extended release | Dextromethorphan, Guaifenesin | United States | Marketed | 2015 |
| LACOSAMIDE200mg/20ml (10mg/ml) · Solution | Lacosamide | United States | Marketed | 2022 |
| LINAGLIPTIN AND METFORMIN HYDROCHLORIDE2.5mg; 1gm | 2.5mg; 500mg | 2.5mg; 850mg · Tablet | Linagliptin, Metformin | United States | Marketed | 2021 |
| LOPURIN100mg | 300mg · Tablet | Allopurinol | United States | Marketed | 1980 |
| MELPHALAN HYDROCHLORIDE50mg base/vial · Injectable | Melphalan | United States | Marketed | 2009 |
| NINTEDANIB ESYLATE100mg base | 150mg base · Capsule | Nintedanib | United States | Marketed | 2026 |
| PAMIDRONATE DISODIUM30mg/10ml (3mg/ml) | 30mg/vial | 60mg/10ml (6mg/ml) | 60mg/vial | 90mg/10ml (9mg/ml) | 90mg/vial · Injectable | Pamidronic acid | United States | Marketed | 2001 |
| PRALATREXATE20mg/ml (20mg/ml) | 40mg/2ml (20mg/ml) · Solution | Pralatrexate% | United States | Marketed | 2025 |
| SODIUM NITROPRUSSIDE25MG/ML | 50MG/VIAL | 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Nitroprusside | United States | Marketed | 1982 |
| SSD1% · Cream | Silver sulfadiazine | United States | Marketed | 1982 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 32 | 31 | 1 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.